CF-Carvacrol
CF-Carvacrol is an orally active lipid-lowering agent synthesized by merging the pharmacophores of Carvacrol (HY-N0711) and Clofibric acid (HY-B1415). CF-Carvacrol has a good affinity for PPAR-α. CF-Carvacrol has significant hypolipidemic activity and may exert antioxidant and anti-inflammatory activity by activating the Nrf2/HO-1 signaling pathway to reduce liver injury. CF-Carvacrol can be used for the study of CF-induced liver damage.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C20H23ClO3
- 분자량:346.85
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Hyperlipidemic KM mice induced by Triton WR 1339 (20 g)[1]
-
Dosage:46.3, 92.6, 185.2 mg/kg
-
Administration:i.g. daily for 7 days
-
Result:Demonstrated notable efficacy in reducing lipid levels and showed reductions in TG levels by 37.5 % (185.2 mg/kg), 24.58 % (92.6 mg/kg ), and 19.31 % (46.3 mg/kg).
-
Animal Model:KM mice (20 g)[1]
-
Dosage:572.3 g/kg
-
Administration:i.g. daily for a month
-
Result:Increased the liver weight and showed lower hepatic injury compared with clofibrate (CF). Decreased ALT and AKP levels. Elevated the levels of plasma SOD and GSH. Elicited minimal oxidative stress response. Decreased TNF-α and IL-6 levels compared to the CF group. Showed no central venous congestion and extensive infiltration of inflammatory cells. Upregulated the expression of Nrf2 and HO-1 proteins.
Chemical Information
-
분자량 346.85
-
화학식 C20H23ClO3
-
SMILES
CC(C1=CC(OC(C(C)(OC2=CC=C(C=C2)Cl)C)=O)=C(C=C1)C)C
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)